These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7513935)

  • 1. The role of the reduced-folate carrier and metabolism to intracellular polyglutamates for the activity of ICI D1694.
    Jackman AL; Gibson W; Brown M; Kimbell R; Boyle FT
    Adv Exp Med Biol; 1993; 339():265-76. PubMed ID: 7513935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical study.
    Jackman AL; Taylor GA; Gibson W; Kimbell R; Brown M; Calvert AH; Judson IR; Hughes LR
    Cancer Res; 1991 Oct; 51(20):5579-86. PubMed ID: 1913676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The measurement of polyglutamate metabolites of the thymidylate synthase inhibitor, ICI D1694, in mouse and human cultured cells.
    Gibson W; Bisset GM; Marsham PR; Kelland LR; Judson IR; Jackman AL
    Biochem Pharmacol; 1993 Feb; 45(4):863-9. PubMed ID: 7680860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymidylate synthase inhibitors: the in vitro activity of a series of heterocyclic benzoyl ring modified 2-desamino-2-methyl-N10-substituted-5,8-dideazafolates.
    Jackman AL; Marsham PR; Moran RG; Kimbell R; O'Connor BM; Hughes LR; Calvert AH
    Adv Enzyme Regul; 1991; 31():13-27. PubMed ID: 1877386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro uptake, anabolism, and cellular retention of 1843U89 and other benzoquinazoline inhibitors of thymidylate synthase.
    Hanlon MH; Ferone R
    Cancer Res; 1996 Jul; 56(14):3301-6. PubMed ID: 8764125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biochemical pharmacology of the thymidylate synthase inhibitor, 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (ICI 198583).
    Jackman AL; Newell DR; Gibson W; Jodrell DI; Taylor GA; Bishop JA; Hughes LR; Calvert AH
    Biochem Pharmacol; 1991 Oct; 42(10):1885-95. PubMed ID: 1741766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and biological studies on 2-desamino-2-methylaminopterin, an antifolate the polyglutamates of which are more potent than the monoglutamate against three key enzymes of folate metabolism.
    Rosowsky A; Galivan J; Beardsley GP; Bader H; O'Connor BM; Russello O; Moroson BA; DeYarman MT; Kerwar SS; Freisheim JH
    Cancer Res; 1992 Apr; 52(8):2148-55. PubMed ID: 1313737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic characteristics of ICI D1694: a quinazoline antifolate which inhibits thymidylate synthase.
    Ward WH; Kimbell R; Jackman AL
    Biochem Pharmacol; 1992 May; 43(9):2029-31. PubMed ID: 1596289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The thymidylate synthase inhibitor, ICI D1694, overcomes translational detainment of the enzyme.
    Keyomarsi K; Samet J; Molnar G; Pardee AB
    J Biol Chem; 1993 Jul; 268(20):15142-9. PubMed ID: 8325888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinazoline thymidylate synthase inhibitors: methods for assessing the contribution of polyglutamation to their in vitro activity.
    Jackman AL; Kimbell R; Brown M; Brunton L; Boyle FT
    Anticancer Drug Des; 1995 Oct; 10(7):555-72. PubMed ID: 7495479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time dependence of DNA lesions and growth inhibition by ICI D1694, a new quinazoline antifolate thymidylate synthase inhibitor.
    Yin MB; Guimaraes MA; Zhang ZG; Arredondo MA; Rustum YM
    Cancer Res; 1992 Nov; 52(21):5900-5. PubMed ID: 1394217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of acquired resistance to the quinazoline thymidylate synthase inhibitor ZD1694 (Tomudex) in one mouse and three human cell lines.
    Jackman AL; Kelland LR; Kimbell R; Brown M; Gibson W; Aherne GW; Hardcastle A; Boyle FT
    Br J Cancer; 1995 May; 71(5):914-24. PubMed ID: 7537518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folate-based thymidylate synthase inhibitors as anticancer drugs.
    Jackman AL; Calvert AH
    Ann Oncol; 1995 Nov; 6(9):871-81. PubMed ID: 8624289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination studies with 3'-azido-3'-deoxythymidine (AZT) plus ICI D1694. Cytotoxic and biochemical effects.
    Pressacco J; Erlichman C
    Biochem Pharmacol; 1993 Dec; 46(11):1989-97. PubMed ID: 8267649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinazoline-based thymidylate synthase inhibitors: relationship between structural modifications and polyglutamation.
    Jackman AL; Kimbell R; Brown M; Brunton L; Bisset GM; Bavetsias V; Marsham P; Hughes LR; Boyle FT
    Anticancer Drug Des; 1995 Oct; 10(7):573-89. PubMed ID: 7495480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ICI D1694, an inhibitor of thymidylate synthase for clinical study.
    Jackman AL; Jodrell DI; Gibson W; Stephens TC
    Adv Exp Med Biol; 1991; 309A():19-23. PubMed ID: 1789205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological activity and intracellular metabolism of ZD1694 in human leukemia cell lines with different resistance mechanisms to antifolate drugs.
    Takemura Y; Kobayashi H; Miyachi H; Gibson W; Kimbell R; Jackman AL
    Jpn J Cancer Res; 1996 Jul; 87(7):773-80. PubMed ID: 8698629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syntheses and thymidylate synthase inhibitory activity of the poly-gamma-glutamyl conjugates of N-[5-[N-(3,4-dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino ]-2-thenoyl]-L-glutamic acid (ICI D1694) and other quinazoline antifolates.
    Bisset GM; Pawelczak K; Jackman AL; Calvert AH; Hughes LR
    J Med Chem; 1992 Mar; 35(5):859-66. PubMed ID: 1372358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation and retention and biological activity of N10-propargyl-5,8-dideazafolic acid (CB3717) polyglutamates in L1210 cells in vitro.
    Sikora E; Jackman AL; Newell DR; Calvert AH
    Biochem Pharmacol; 1988 Nov; 37(21):4047-54. PubMed ID: 2461200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ICI D1694 and idoxuridine: a synergistic antitumor combination.
    Pressacco J; Hedley DW; Erlichman C
    Cancer Res; 1994 Jul; 54(14):3772-8. PubMed ID: 8033097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.